NGM Biopharmaceuticals, Inc. is a clinical stage biotech company dedicated to discovering and developing the next generation of medicines for the treatment of serious diseases. Our experienced scientific team has joined forces with an impressive group of industry professionals, Nobel Laureates and other distinguished researchers to form a company where innovation and cutting-edge science has provided the foundation for a robust drug discovery engine. To date, NGM Bio has generated a pipeline of seven drug candidates in various stages of development targeting liver, metabolic and ophthalmic diseases and cancer. The most advanced drug candidate, NGM282, is entering Phase 2b clinical studies in non-alcoholic steatohepatitis (NASH). NGM’s strategic collaboration with Merck, which was extended to March 2022, will continue to provide us with the resources and flexibility to pursue our ambitious R&D goals and further extend our pipeline of novel drug candidates.
NGM is looking for a senior accountant with a strong understanding of month end accruals. Prior experience owning clinical trial accruals gives this candidate an edge. The best candidate has a high sense of urgency, strictly adheres to close timelines, and loves being part of a hard-working, committed and fun team. He/she will be responsible for preparing all clinical trial and research accruals on a monthly basis, and will collaborate with the clinical operations, project management, research, contracts, finance & accounting groups. This position reports to the senior accounting manager.
Required Skills
Required Experience
EDUCATION/ BACKGROUND:
OTHER REQUIREMENTS:
NGM offers a creative, collaborative, highly challenging scientific environment, along with a strong compensation package that includes salary, stock options, 401(k) and a comprehensive benefits package.
Interested applicants should apply through the NGM Biopharmaceuticals website: http://www.ngmbio.com/careers/#SilkroadFrame